我国药品不良反应监测面临的问题与改进方向

Problems and directions of improvement for adverse drug reactions monitoring in China

我国药品不良反应监测工作近十年来从无到有,取得成绩的同时也由于医药卫生领域机制体制有待改革而存在诸多问题。文中就目前存在的问题,如针剂和大输液、抗微生物药物、激素等的滥用;医疗经营重利轻责;药品监管执法力度不足;药监局与卫生部的协调及中药不合理用药等对我国药品不良反应监测的不利影响进行了分析,提出要遵从先进文化的发展方向,用唯物史观和以人为本的要求看待现有问题,建立并完善药品不良反应监测的规章制度,为确保广大人民群众用上安全有效的放心药而不懈努力。

Adverse drug reactions monitoring in China is now beginning its second decade. Achievements are outstanding but many problems caused by system organization remain to be solved.The authors discussed the following problems： abuse of injections, antibiotics and corticosteroids; money focused trend of medical services; the weakness of drug administration power; insufficient coordination between SFDA and MoH, irrational use of Chinese traditional medicines.These problems that produced adverse impact on adverse drug reactions monitoring were analyzed, and countermeasures were put forward i.e.complying with the development direction of advanced culture, and regard present problems with historical materialism and insisting on “people-centred” idea, and build and complete an effective adverse drug reactions monitoring system, and extremely do our best to ensure the broad masses accessible to safe, effective and reassurance medicines.